User profiles for Justine Rudewicz
Justine RudewiczUniversity of Bergen Verified email at uib.no Cited by 287 |
[HTML][HTML] SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia
…, J Dejaegher, L Solie, J Rudewicz… - The Journal of …, 2021 - Am Soc Clin Investig
SLIT2 is a secreted polypeptide that guides migration of cells expressing Roundabout 1 and
2 (ROBO1 and ROBO2) receptors. Herein, we investigated SLIT2/ROBO signaling effects in …
2 (ROBO1 and ROBO2) receptors. Herein, we investigated SLIT2/ROBO signaling effects in …
TGF-β promotes microtube formation in glioblastoma through thrombospondin 1
Background Microtubes (MTs), cytoplasmic extensions of glioma cells, are important cell
communication structures promoting invasion and treatment resistance through network …
communication structures promoting invasion and treatment resistance through network …
[HTML][HTML] Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression
LS Cooley, J Rudewicz, W Souleyreau, A Emanuelli… - Molecular cancer, 2021 - Springer
Background Renal Cell Carcinoma (RCC) is difficult to treat with 5-year survival rate of 10%
in metastatic patients. Main reasons of therapy failure are lack of validated biomarkers and …
in metastatic patients. Main reasons of therapy failure are lack of validated biomarkers and …
Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis
…, A Barre, B Dartigues, S Karkar, J Rudewicz… - EMBO molecular …, 2022 - embopress.org
Lactate is a central metabolite in brain physiology but also contributes to tumor development.
Glioblastoma (GB) is the most common and malignant primary brain tumor in adults, …
Glioblastoma (GB) is the most common and malignant primary brain tumor in adults, …
[HTML][HTML] Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or …
N Quenel-Tueux, M Debled, J Rudewicz… - British Journal of …, 2015 - nature.com
Background: The aim of this study was to assess the efficacy of neoadjuvant anastrozole
and fulvestrant treatment of large operable or locally advanced hormone-receptor-positive …
and fulvestrant treatment of large operable or locally advanced hormone-receptor-positive …
The invasive proteome of glioblastoma revealed by laser-capture microdissection
…, AA Raymond, B Dartigues, J Rudewicz… - Neuro-Oncology …, 2019 - academic.oup.com
Background Glioblastomas are heterogeneous tumors composed of a necrotic and tumor
core and an invasive periphery. Methods Here, we performed a proteomics analysis of laser-…
core and an invasive periphery. Methods Here, we performed a proteomics analysis of laser-…
[HTML][HTML] Antioxydation and cell migration genes are identified as potential therapeutic targets in basal-like and brca1 mutated breast cancer cell lines
M Privat, J Rudewicz, N Sonnier… - … journal of medical …, 2018 - ncbi.nlm.nih.gov
Basal-like breast cancers are among the most aggressive cancers and effective targeted
therapies are still missing. In order to identify new therapeutic targets, we performed Methyl-Seq …
therapies are still missing. In order to identify new therapeutic targets, we performed Methyl-Seq …
The hexosamine pathway and coat complex II promote malignant adaptation to nutrient scarcity
…, C Machon, J Guitton, J Rudewicz… - Life Science …, 2022 - life-science-alliance.org
The glucose-requiring hexosamine biosynthetic pathway (HBP), which produces UDP-N-acetylglucosamine
for glycosylation reactions, promotes lung adenocarcinoma (LUAD) …
for glycosylation reactions, promotes lung adenocarcinoma (LUAD) …
Validation of a yeast functional assay for p53 mutations using clonal sequencing
R Iggo, J Rudewicz, E Monceau… - The Journal of …, 2013 - Wiley Online Library
We have previously tested biopsies from 1469 breast tumours with a p53 functional assay in
the context of a prospective clinical trial ( EORTC 10994/ BIG 1–00). The goal of the trial …
the context of a prospective clinical trial ( EORTC 10994/ BIG 1–00). The goal of the trial …
[HTML][HTML] MICADo–looking for mutations in targeted PacBio cancer data: an alignment-free method
J Rudewicz, H Soueidan, R Uricaru, H Bonnefoi… - Frontiers in …, 2016 - frontiersin.org
Targeted sequencing is commonly used in clinical application of NGS technology since it
enables generation of sufficient sequencing depth in the targeted genes of interest and thus …
enables generation of sufficient sequencing depth in the targeted genes of interest and thus …